Class IIOngoingVoluntary: Firm initiated

UPSTATE NIAGARA COOPERATIVE: food recall H-1332-2026

UPSTATE NIAGARA COOPERATIVE of Lancaster, NY recalled Mehadrin Chocolate Leben; 6 OZ (170g) CUPS, UPC: 070784023144. Reason: Product may have been improperly pasteurized. The FDA listed it as Class II in its Enforcement Report dated Sep 2, 2026; distribution: New Jersey.

Record status as published: Ongoing. openFDA data last updated Oct 21, 2026.

Have this product? Check FDA.gov and your retailer. This page reproduces an FDA Enforcement Report record and is not a public alert. Look for the firm's recall notice on the FDA's recalls page, or ask the store where you bought it what to do. If you think you got sick from a food, contact a health care provider.

Recall details

Product
Mehadrin Chocolate Leben; 6 OZ (170g) CUPS, UPC: 070784023144
Product quantity
3,975 cases
Reason for recall
Product may have been improperly pasteurized.
Codes, lots and dates on the package
Lot code: 101426 L5 2W Use by date: 10/14/26
Distribution pattern
NJ
Recalling firm
UPSTATE NIAGARA COOPERATIVE, Lancaster, NY
Classification
Class II — the FDA uses this class for a situation in which using or being exposed to the product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
Voluntary or mandated
Voluntary: Firm initiated
How the firm first notified customers
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Dates

EventDate
Recall initiated by the firmAug 10, 2026
Classified by the FDASep 4, 2026
Published in the Enforcement ReportSep 2, 2026

All food recall records

OpenPlate shows FDA records as published and does not add new findings. Product names and company names belong to their owners.

Sources

  • U.S. Food and Drug Administration, openFDA food enforcement reports, recall number H-1332-2026 (openFDA record). Data provided by the U.S. Food and Drug Administration (https://open.fda.gov).
  • Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service. The FDA does not endorse OpenPlate.